Reduced risk of recurrent pneumothorax for sirolimus therapy after surgical pleural covering of entire lung in lymphangioleiomyomatosis

Reduced risk of recurrent pneumothorax for sirolimus therapy after surgical pleural covering of entire lung in lymphangioleiomyomatosis

Abstract Background Patients with lymphangioleiomyomatosis (LAM) frequently experience pneumothorax. Although sirolimus is the standard therapy for LAM, its effect on pneumothorax is controversial. Recently, total pleural covering (TPC) and modified TPC (mTPC) were introduced as surgical treatment o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Teiko Sakurai, Toru Arai, Masaki Hirose, Kensuke Kojima, Tetsuki Sakamoto, Yoshinobu Matsuda, Chikatoshi Sugimoto, Hyung-Eun Yoon, Yoshikazu Inoue
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Lymphangioleiomyomatosis
Pneumothorax
Sirolimus
Vascular endothelial growth factor D
Total pleural covering
Surgical pleural covering
Medicine
R
Acceso en línea:https://doaj.org/article/fee158e7a1ac487b97531e02ca80e47b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares